论文部分内容阅读
目的观察金葡液治疗卵巢癌腹水的临床疗效。方法随机将卵巢癌腹水患者分为2组:一组用金葡液,抽尽腹水后,腹腔内注入金葡液2 000 IU;另一组用顺铂,腹腔内注入顺铂100 mg/m2。结果金葡液组治疗有效率为83%,顺铂组为75%,2组比较无显著性差异(P>0.05)。在活动状况提高方面,2组比较无显著性差异(P>0.05)。不良反应金葡液组少于顺铂组(P<0.01)。结论金葡液是治疗卵巢癌腹水的有效药物,其不良反应较顺铂少。
Objective To observe the clinical efficacy of Jin-Jin liquid in the treatment of ascites of ovarian cancer. Methods Patients with ascites of ovarian cancer were randomly divided into two groups: one group with gold grape juice, pumping ascites after intraperitoneal injection of gold I 2 000 IU; the other group with cisplatin, intraperitoneal injection of cisplatin 100 mg / m2 . Results The effective rate of Jinpeijin group was 83% and that of cisplatin group was 75%. There was no significant difference between the two groups (P> 0.05). There was no significant difference between the two groups in activity status (P> 0.05). Adverse reactions of gold grape liquid group was less than cisplatin group (P <0.01). Conclusion Jinpeijin is an effective drug for treatment of ascites of ovarian cancer, with less adverse reactions than cisplatin.